Observational study on outcomes after hip and knee replacements
QIST Collaborative - Arthroplasty Research Cohort (ARC) Study - a Collaborative, Longitudinal Observational Cohort Study of Patients Undergoing Primary Hip and Knee Replacements in the United Kingdom
This study looks at how people feel and do after getting hip and knee replacements to find ways to improve their care in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Northumbria Healthcare NHS Foundation Trust Academic / other |
| Locations | 1 site (Ashington) |
| Trial ID | NCT05824845 on ClinicalTrials.gov |
What this trial studies
The ARC Study is a national observational cohort study aimed at investigating patient-reported and clinical outcomes following hip and knee replacements. It evaluates outcomes, identifies risk factors for adverse outcomes, and seeks to establish targets for future research and interventions. Participants are recruited online and through outpatient clinics, providing a resource for identifying potential participants for future clinical trials. The study collects data that can serve as comparison or control data for randomized trial participants.
Who should consider this trial
Good fit: Ideal candidates are UK residents aged 18 and over who are undergoing elective primary hip or knee arthroplasty.
Not a fit: Patients who do not meet the inclusion criteria or are not undergoing elective hip or knee replacements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of outcomes and risks associated with hip and knee replacements, leading to better patient care.
How similar studies have performed: Other studies have shown success in similar observational approaches, indicating the potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants must meet all of the inclusion criteria: 1. UK Resident 2. Able to read and understand documentation and questionnaires in English language 3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR) 4. Age 18 years or over 5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials Exclusion Criteria: Provided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.
Where this trial is running
Ashington
- Northumbria Healthcare NHS Foundation Trust — Ashington, United Kingdom (Recruiting)
Study contacts
- Study coordinator: William Fishley
- Email: arcstudy@northumbria-healthcare.nhs.uk
- Phone: 01912934087
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.